Landscapes / Companies
United Therapeutics not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
4
in active trials · 9 in all
Trials
8 active
34 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Prostacycline vasodilator |
Approved | Nov 2027Phase 3 trial completes | |||
| Next date | Nov 2027 · Phase 3 trial completes | ||||
| Also tested for | Interstitial Lung Disease, Progressive Pulmonary Fibrosis and 3 more | ||||
| Open drug page | |||||
— |
Phase 3 | Dec 2026Phase 3 trial completes | |||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | PAH, Pulmonary Hypertension and 9 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Oct 2028Phase 1/2 trial completes | |||
| Next date | Oct 2028 · Phase 1/2 trial completes | ||||
| Also tested for | ESRD (End-Stage Renal Disease), Kidney Transplantation and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Nov 2029Phase 1/2 trial completes | |||
| Next date | Nov 2029 · Phase 1/2 trial completes | ||||
| Also tested for | ESRD (End-Stage Renal Disease), Kidney Transplantation and 1 more | ||||
| Open drug page | |||||
About
- No active trial
- treprostinil diethanolamine, Treprostinil Inhalation Powder, treprostinil Sustained Release, Tyvaso Inhalation, UNEX-42
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021